Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ewing, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

SEC filing history

Showing 301-325 of 688 matching filings.

Per page
25
Current page
13
8-K File 001-32302

8-K

Filing date
08 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
12 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
02 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
22 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K ITEM 5.07

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K INVESTOR PRESENTATION

Filing date
08 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

FORM 8-K

Filing date
07 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-217808

EFFECT filing

Filing date
18 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-217808

FORM S-3

Filing date
09 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-32302

ATRS-10Q-20170331

Filing date
09 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
8-K File 001-32302

8-K Q12017 PRESS RELEASE

Filing date
09 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-32302

DEF 14A

Filing date
27 Apr 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Apr 2017
Reporting date
04 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .